F-star Therapeutics, Inc. Quarterly Interest Expense in USD from Q3 2019 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
F-star Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q3 2019 to Q3 2022.
  • F-star Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2022 was $378K, a 16.3% increase year-over-year.
  • F-star Therapeutics, Inc. Interest Expense for the twelve months ending September 30, 2022 was $1.34M.
  • F-star Therapeutics, Inc. annual Interest Expense for 2021 was $844K, a 15.7% decline from 2020.
  • F-star Therapeutics, Inc. annual Interest Expense for 2020 was $1M, a 84.7% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $1.34M $378K +$53K +16.3% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $1.29M $334K +$224K +204% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.07M $308K +$221K +254% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $844K $322K Oct 1, 2021 Dec 31, 2021 10-K 2022-03-15
Q3 2021 $325K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $110K +$75K +214% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $87K -$389K -81.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q2 2020 $35K Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $476K Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-07
Q3 2019 $63K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.